Literature DB >> 2546618

Receptors for erythropoietin in mouse and human erythroid cells and placenta.

S T Sawyer1, S B Krantz, K Sawada.   

Abstract

High and lower affinity receptors for erythropoietin (EP) were initially identified on a very pure population of EP-responsive erythroblasts obtained from the spleens of mice infected with anemia strain of Friend virus (FVA). The structure of the receptor for EP in these cells was determined to be proteins of 100 and 85 Kd by cross-linking 125I-EP. In this investigation, studies on the receptors for EP were extended to other mouse erythroid cells and human erythroid cells as well as to the placentas of mice and rats. Only lower affinity receptors for EP were detected on erythroblasts purified from the spleens of mice infected with the polycythemia strain of Friend virus and a murine erythroleukemia cell line, both of which are not responsive to EP in culture. Internalization of 125I-EP was observed in both groups of cells. The structure of the receptor determined by cross-linking 125I-EP was two equally labeled proteins of 100 Kd and 85 Kd molecular mass in all these mouse erythroid cells. The structure of the receptor was found to be very similar in human erythroid colony forming cells cultured from normal blood. These cells respond to EP with erythroid maturation and were previously shown to have high and lower affinity receptors. Placentas from mice and rats were found to have only lower affinity receptors for EP, and when placental membranes were cross-linked to 125I-EP, the same 100 Kd and 85 Kd bands were found as seen in mouse and human erythroid cells. The structure of the receptor was similar in cells that have high affinity receptors (FVA-infected and human erythroid colony-forming cells) and nonresponsive erythroid cells and placenta that have lower affinity receptors, but only the cells with the high affinity receptors respond to the addition of EP with erythroid maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546618

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium.

Authors:  H Kimata; A Yoshida; C Ishioka; S Masuda; R Sasaki; H Mikawa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 2.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 3.  Erythropoietin receptor. Subunit structure and activation.

Authors:  A D D'Andrea; L I Zon
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Erythropoietin receptors in polycythemia vera.

Authors:  R T Means; S B Krantz; S T Sawyer; H S Gilbert
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling.

Authors:  Akanksha Chhabra; Andrew J Lechner; Masaya Ueno; Asha Acharya; Ben Van Handel; Yanling Wang; M Luisa Iruela-Arispe; Michelle D Tallquist; Hanna K A Mikkola
Journal:  Dev Cell       Date:  2012-03-01       Impact factor: 12.270

6.  Differential gene expression during terminal erythroid differentiation.

Authors:  S Koury; S Yarlagadda; K Moskalik-Liermo; N Popli; N Kim; C Apolito; A Peterson; X Zhang; P Zu; J Tamburlin; D Bofinger
Journal:  Genomics       Date:  2007-08-31       Impact factor: 5.736

7.  TRPC3 activation by erythropoietin is modulated by TRPC6.

Authors:  Iwona Hirschler-Laszkiewicz; Qin Tong; Kathleen Conrad; Wenyi Zhang; Wesley W Flint; Alistair J Barber; Dwayne L Barber; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

8.  Specific inhibition of interleukin 3 bioactivity by a monoclonal antibody reactive with hematopoietic progenitor cells.

Authors:  P D Emanuel; S C Peiper; Z Chen; D C Sheng; K S Zuckerman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury.

Authors:  Alberto Pinzon; Alexander Marcillo; Diego Pabon; Helen M Bramlett; Mary Bartlett Bunge; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2008-07-14       Impact factor: 5.330

10.  Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system.

Authors:  A Malek; R Sager; K U Eckardt; C Bauer; H Schneider
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.